𝔖 Bobbio Scriptorium

✦ LIBER ✦

Recent progress concerning CpG DNA and its use as a vaccine adjuvant

✍ Scribed by Shirota, Hidekazu; Klinman, Dennis M

Book ID: 121862557
Publisher: Expert Reviews
Year: 2013
Tongue: English
Weight: 409 KB
Volume: 13
Category: Article
ISSN: 1476-0584
DOI: 10.1586/14760584.2014.863715

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

cDNA clone of non-A non-B hepatitis viru

cDNA clone of non-A non-B hepatitis virus (NANB) post transfusion and its use — DNA sequence; potential application as recombinant vaccine; DNA probe application in disease diagnosis

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Breaking B and T cell tolerance using ca

Breaking B and T cell tolerance using cationic lipid–DNA complexes (CLDC) as a vaccine adjuvant with hepatitis B virus (HBV) surface antigen in transgenic mice expressing HBV

✍ John D. Morrey; Neil E. Motter; Stella Chang; Jeffery Fairman 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 462 KB

Stimulating humoral response with antige

Stimulating humoral response with antigen and CD83 protein of DNA: expression from a bacterium or a virus vector, for use as a recombinant vaccine adjuvant, for e.g. autoimmune disease, transplant rejection, allergy, asthma, etc. prevention : Immunex World 9729 781; 21 August 1997

📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 160 KB